Anastasia Khodakova

Anastasia is responsible for validation of small RNA disease models and biomarker assay development in support of Gatehouse Bio’s R&D pipeline. The scope of her work includes design and optimization of high-throughput RT-qPCR assays and the R&D activity to establish a link between sequencing and RT-qPCR data.

Prior to joining Gatehouse Bio, Anastasia was a Postdoctoral Fellow at the Baylor College of Medicine where she studied molecular pathways regulating host-microbiome interactions using C. elegans as a model organism.